Intercontinental Controller Oncology

Reporting to: Corporate Oncology & RoW Controlling Manager Key stakeholders: Corporate Finance, RoW Commercial, Supply Chain, Market Access, Legal, Business Development, distribution partners The Rest of the World (RoW) Controller for Stemline Oncology Business is responsible for coordinating, controlling, and reporting the financial performance of international markets (excluding the US), ensuring accuracy, transparency, and robustness of financial data.